Health4 weeks ago
Abivax Shares Surge 400% Following Successful Ulcerative Colitis Trials
Shares of Abivax experienced a remarkable increase of over 400% on October 25, 2023, following the announcement of significant progress in its late-stage trials for obefazimod,...
